Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Effects of sapropterin on endothelium-dependent vasodilation in patients with CADASIL: a randomized controlled trial.
[cadasil]
Cerebral
autosomal-dominant
arteriopathy
with
subcortical
infarcts
and
leukoencephalopathy
(
CADASIL
)
,
a
rare
autosomal
dominant
disorder
caused
by
NOTCH
3
mutations
,
is
characterized
by
vascular
smooth
muscle
and
endothelial
cells
abnormalities
,
altered
vasoreactivity
,
and
recurrent
lacunar
infarcts
.
Vasomotor
function
may
represent
a
key
factor
for
disease
progression
.
Tetrahydrobiopterin
,
essential
cofactor
for
nitric
oxide
synthesis
in
endothelial
cells
,
ameliorates
endothelial
function
.
We
assessed
whether
supplementation
with
sapropterin
,
a
synthetic
tetrahydrobiopterin
analog
,
improves
endothelium-dependent
vasodilation
in
CADASIL
patients
.
In
a
24
-
month
,
multicenter
randomized
,
double
-blind
,
placebo-controlled
trial
,
CADASIL
patients
aged
30
to
65
years
were
randomly
assigned
to
receive
placebo
or
sapropterin
200
to
400
mg
BID
.
The
primary
end
point
was
change
in
the
reactive
hyperemia
index
by
peripheral
arterial
tonometry
at
24
months
.
We
also
assessed
the
safety
and
tolerability
of
sapropterin
.
Analysis
was
done
by
intention-
to
-treat
.
The
intention-
to
-treat
population
included
61
patients
.
We
found
no
significant
difference
between
sapropterin
(
n
=
32
)
and
placebo
(
n
=
29
)
in
the
primary
end
point
(
mean
difference
in
reactive
hyperemia
index
by
peripheral
arterial
tonometry
changes
0
.
19
[
95
%
confidence
interval
,
-
0
.
18
,
0
.
56
]
)
.
Reactive
hyperemia
index
by
peripheral
arterial
tonometry
increased
after
24
months
in
37
%
of
patients
on
sapropterin
and
in
28
%
on
placebo
;
however
,
after
adjustment
for
age
,
sex
,
and
clinical
characteristics
,
improvement
was
not
associated
with
treatment
arm
.
The
proportion
of
patients
with
adverse
events
was
similar
on
sapropterin
and
on
placebo
(
50
%
versus
48
.
3
%
)
;
serious
adverse
events
occurred
in
6
.
3
%
versus
13
.
8
%
,
respectively
.
Sapropterin
was
safe
and
well-tolerated
at
the
average
dose
of
5
mg
/
kg
/
day
,
but
did
not
affect
endothelium-dependent
vasodilation
in
CADASIL
patients
.
https
:
/
/
www
.
clinicaltrialsregister
.
eu
.
Unique
identifier
:
2007
-
004370
-
55
.
Diseases
Validation
Diseases presenting
"is characterized by vascular smooth muscle and endothelial cells abnormalities"
symptom
cadasil
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom